MPM BioVentures 2014
Venture capitalCambridge
Fund manager profile
MPM BioVentures 2014 is a venture fund manager based in Cambridge. SEC filings show 1 venture fund on record, most recently MPM BioVentures 2014, L.P. ($347.3M offering) filed July 2015.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 1 of 1 portfolio companiesBiotech ×1Healthtech ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathAligos is a clinical-stage biotechnology company developing therapeutics for liver and viral diseases, including chronic hepatitis B virus (HBV) infection and MASLD/MASH.
BiotechHealthtechSouth San Francisco, US
Hardean Achneck(Executive Officer)Carole Neuchterlein(Director)Peter Moldt(Director)Sushmita Chanda(Executive Vice President - Preclinical Development)Kathleen Glaub(Director)Brian Dowd(Executive Vice President - Controller)
Board seatJames Scopa· per SEC Form D · $92.2M raise · filed Nov 2023
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- Where is MPM BioVentures 2014 located?
- MPM BioVentures 2014 is headquartered in Cambridge, US.